Literature DB >> 22870432

Paget's Disease of Bone: A Review of Epidemiology, Pathophysiology and Management.

Joseph L Shaker.   

Abstract

Paget's disease of bone is a common disorder which may affect one or many bones. Although many patients are asymptomatic, a variety of symptoms and complications may occur. Fortunately, effective pharmacologic therapy, primarily with potent bisphosphonates, is now available to treat patients with complications or symptoms. This review of Paget's disease of bone will include epidemiology and pathophysiology, complications and clinical findings, indications for treatment, and the drugs currently available to treat this condition.

Entities:  

Keywords:  Paget's disease of bone; bisphosphonates; osteoclasts

Year:  2009        PMID: 22870432      PMCID: PMC3383486          DOI: 10.1177/1759720X09351779

Source DB:  PubMed          Journal:  Ther Adv Musculoskelet Dis        ISSN: 1759-720X            Impact factor:   5.346


  166 in total

Review 1.  Is the prevalence of Paget's disease of bone decreasing?

Authors:  Tim Cundy
Journal:  J Bone Miner Res       Date:  2006-12       Impact factor: 6.741

2.  Paget disease manifesting with compressive sixth-nerve palsy that resolved with intravenous zoledronic acid therapy.

Authors:  Anthony Pane
Journal:  Arch Ophthalmol       Date:  2007-10

3.  Association of Paget's disease of bone with calcific aortic valve disease.

Authors:  S A Strickberger; S P Schulman; G M Hutchins
Journal:  Am J Med       Date:  1987-05       Impact factor: 4.965

4.  Intravenously administered pamidronate in the treatment of Paget's disease of bone.

Authors:  J R Tucci; S Bontha
Journal:  Endocr Pract       Date:  2001 Nov-Dec       Impact factor: 3.443

5.  A randomized, double-blind comparison of risedronate and etidronate in the treatment of Paget's disease of bone. Paget's Risedronate/Etidronate Study Group.

Authors:  P D Miller; J P Brown; E S Siris; M S Hoseyni; D W Axelrod; P J Bekker
Journal:  Am J Med       Date:  1999-05       Impact factor: 4.965

6.  Long-term control of bone turnover in Paget's disease with zoledronic acid and risedronate.

Authors:  David Hosking; Kenneth Lyles; Jacques P Brown; William D Fraser; Paul Miller; Manuel Diaz Curiel; Jean-Pierre Devogelaer; Michael Hooper; Guoqin Su; Ken Zelenakas; Judy Pak; Taiwo Fashola; Youssef Saidi; Erik Fink Eriksen; Ian R Reid
Journal:  J Bone Miner Res       Date:  2007-01       Impact factor: 6.741

7.  Evaluation of the role of Valosin-containing protein in the pathogenesis of familial and sporadic Paget's disease of bone.

Authors:  Gavin J A Lucas; Sarju G Mehta; Lynne J Hocking; Tracy L Stewart; Tim Cundy; Geoff C Nicholson; John P Walsh; William D Fraser; Giles D J Watts; Stuart H Ralston; Virginia E Kimonis
Journal:  Bone       Date:  2005-09-30       Impact factor: 4.398

8.  A single infusion of the bisphosphonate AHPrBP (APD) as treatment of Paget's disease of bone.

Authors:  D Thiébaud; P Jaeger; C Gobelet; A F Jacquet; P Burckhardt
Journal:  Am J Med       Date:  1988-08       Impact factor: 4.965

Review 9.  Denosumab: anti-RANKL antibody.

Authors:  Paul D Miller
Journal:  Curr Osteoporos Rep       Date:  2009-03       Impact factor: 5.096

10.  Absence of paramyxovirus RNA in cultures of pagetic bone cells and in pagetic bone.

Authors:  M A Birch; W Taylor; W D Fraser; S H Ralston; C A Hart; J A Gallagher
Journal:  J Bone Miner Res       Date:  1994-01       Impact factor: 6.741

View more
  13 in total

1.  A rare case of Paget's disease affecting the cervical spine.

Authors:  J Holton; M Jones; Z Klezl; M Czyz; M Grainger; P Rehousek
Journal:  Ann R Coll Surg Engl       Date:  2018-10-16       Impact factor: 1.891

Review 2.  Molecular genetics of osteosarcoma.

Authors:  Kirby Rickel; Fang Fang; Jianning Tao
Journal:  Bone       Date:  2016-10-17       Impact factor: 4.398

Review 3.  Paget's Disease of Bone: Osteoimmunology and Osteoclast Pathology.

Authors:  Emily M Rabjohns; Katlyn Hurst; Arin Ghosh; Maria C Cuellar; Rishi R Rampersad; Teresa K Tarrant
Journal:  Curr Allergy Asthma Rep       Date:  2021-03-25       Impact factor: 4.806

4.  Osteoporotic Fractures among Selective Estrogen Receptor Modulator Users in South Korea: Analysis Using National Claims Database.

Authors:  Jung-Wee Park; Young-Kyun Lee; Yangseon Choi; Yong-Chan Ha
Journal:  J Bone Metab       Date:  2022-05-31

5.  Is Paget Disease of Bone more Common in South India? Clinical Characteristics, Therapeutic Outcome and follow-up of 66 Patients from Tamil Nadu.

Authors:  Adlyne R Asirvatham; Subramanian Kannan; Shriraam Mahadevan; Karthik Balachandran; Geethalakshmi Sampathkumar; Dhalapathy Sadacharan; Satish K Balasubramanian
Journal:  Indian J Endocrinol Metab       Date:  2020-08-27

Review 6.  Bone Microvasculature: Stimulus for Tissue Function and Regeneration.

Authors:  Eun-Jin Lee; Mahim Jain; Stella Alimperti
Journal:  Tissue Eng Part B Rev       Date:  2020-10-22       Impact factor: 7.376

Review 7.  Current perspectives on bisphosphonate treatment in Paget's disease of bone.

Authors:  Winnie Zee Man Wat
Journal:  Ther Clin Risk Manag       Date:  2014-11-20       Impact factor: 2.423

Review 8.  Epidemiology and pathology of Paget's disease of bone - a review.

Authors:  Elena Nebot Valenzuela; Peter Pietschmann
Journal:  Wien Med Wochenschr       Date:  2016-09-06

Review 9.  An Insight in to Paget's Disease of Bone.

Authors:  Robin Sabharwal; Shivangi Gupta; Shipra Sepolia; Rajat Panigrahi; Saumyakanta Mohanty; Santosh Kumar Subudhi; Manish Kumar
Journal:  Niger J Surg       Date:  2014-01

10.  Chronic femoral diaphyseal osteomyelitis with radiographs initially concerning for Paget disease of the bone.

Authors:  Seth A Reasoner; Juan M Colazo; Jonathan Tucci; Justin Cates; Kathryn M Dahir
Journal:  Radiol Case Rep       Date:  2020-01-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.